Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05581004 |
|---|---|
| Brief Title: | A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors |
| First Submitted : | October 12, 2022 |
| First Submitted that Met QC Criteria : | October 12, 2022 |
| First Posted : | October 14, 2022 |
| Last Update Submitted that Met QC Criteria : | May 16, 2024 |
| Last Update Posted : | May 20, 2024 (Estimate) |